Phenobarbital and Diazepam Yielded Similar Withdrawal Outcomes

Large study found comparable results for patients hospitalized with alcohol withdrawal syndrome.

Updated on Oct. 14, 2026 in Substance Abuse

Isometric editorial illustration of two glass laboratory flasks, one containing amber liquid and one containing clear liquid, comparing clinical treatments.
A study of 24,000 patients found that phenobarbital and diazepam produce similar clinical outcomes for patients with alcohol withdrawal syndrome. AI Illustration. Upload story photo >

Live Poll

Should hospitals rely on newer treatment protocols for alcohol withdrawal rather than long-established medical standards?

An observational study of over 24,000 patients treated between 2022 and 2024 found that phenobarbital and diazepam produce similar outcomes for alcohol withdrawal syndrome. The research offers new evidence for clinicians managing this condition in hospitals.

Why it matters

Clinicians have increasingly turned to phenobarbital due to dissatisfaction with shorter-acting benzodiazepines, which can lead to breakthrough symptoms. This study helps clarify whether phenobarbital is as effective and safe as longer-acting options.

This observational study tracked over 24,000 patients at 754 hospitals to compare treatment outcomes. While phenobarbital use grew by over 200% between 2016 and 2020, future research is still required to define ideal treatment strategies.

The details

Researchers compared outcomes for patients admitted with a primary diagnosis of alcohol withdrawal syndrome who received either phenobarbital or diazepam. Roughly two-thirds of patients in both treatment groups received additional benzodiazepines on the day of admission. Clinicians moved toward phenobarbital in recent years to avoid the breakthrough symptoms and sleepiness often associated with shorter-acting treatments.

Timeline

  1. 1960s: Diazepam was established as the standard treatment for alcohol withdrawal.

  2. 2016-2020: Phenobarbital usage rates increased by more than 200%.

  3. 2022-2024: The study tracked outcomes for over 24,000 hospitalized patients.

Health Landscape

This study suggests a potential shift in the clinical standards set in the 1960s when diazepam became the primary treatment for alcohol withdrawal. It highlights an evolving approach to managing withdrawal symptoms as medical teams seek alternatives to traditional benzodiazepines.

If you or a loved one require hospitalization for alcohol withdrawal, it is worth discussing the facility's specific protocols with the care team. Understanding which medications are used and why can help you and your physician make informed decisions about your care.

The takeaway

Large-scale data suggests that phenobarbital and diazepam may be comparable in treating alcohol withdrawal symptoms in a hospital setting. Patients should consult with their healthcare provider about the risks and benefits of various withdrawal protocols.

Further reading

For more information on managing dependency and care, visit our Substance Abuse section.

Source note: This article includes information reported by Medscape.

Live Poll

Should hospitals rely on newer treatment protocols for alcohol withdrawal rather than long-established medical standards?